Sunday, 1 January 2017

ADA 2017 Standards of Medical Care in Diabetes

Dr K K Aggarwal, National President IMA

The American Diabetes Association (ADA) has released its new Standards of Medical Care in Diabetes for the year 2017. The guidelines have especially focused on psychological health, access to care, expanded and personalized treatment options, and the tracking of hypoglycemia in people with diabetes.

Some salient features of the new Standards of care include:

·         Guidelines on screening adults and youth with diabetes for diabetes distress, depression, anxiety and eating disorders; a list of situations that warrant a referral to a mental health specialist is also included.
·         An expanded list of diabetes comorbidities now includes autoimmune disease, HIV, anxiety disorders, depression, disordered eating behavior and serious mental illness.
·         New lifestyle management guidelines include a physical activity recommendation to interrupt prolonged sedentary behavior every 30 minutes.
·         Sleep patterns should be assessed as part of overall diabetes care because sleep quality may be associated with blood glucose management.
·         The indications for metabolic surgery have been expanded to include patients with inadequately controlled type 2 diabetes who have a BMI as low as 30 kg/m2 (27.5 kg/m2 in Asian Americans).
·         Any of the four classes of blood pressure medications that have shown beneficial cardiovascular outcomes in people with diabetes - ACE inhibitors, angiotensin receptor blockers, thiazide-like diuretics or dihydropyridine calcium channel blockers - may now be used as first-line treatment for hypertension.
·         Anew insulin algorithm included in the guidelines offers more glucose management options for people with type 2 diabetes.
·         The Standards include a new recommendation to consider the GLP-1 receptor agonist liraglutide and the SGLT-2 inhibitor empagliflozin in patients with diabetes and CV disease (history of stroke or heart attack, acute coronary syndromes, angina or peripheral arterial disease) to reduce risk of death.
·         A level of less than 54mg/dl is now defined as denoting serious clinically important hypoglycemia.
·         To help reduce health disparities, the Standards now recommend people with diabetes receive self-management support from lay health coaches, navigators and community health workers.
The Standards are available online on Dec. 15, 2016, and will be published as a supplement to the January 2017 issue of Diabetes Care.


(Source: ADA Press Release, December 15, 2016)

1 comment:


  1. *I've been diagnosed with Crohn's disease 2 years ago. i Tried every
    treatment traditional could give me: Immunosuppressive drug, anti-tnf,
    cortisone etc. Nothing worked. Medical Marijuana is my last hope.
    Unfortunately I live in France. a friend introduce me to this great man
    called dr jatto i told him my problem and he give me some tips about his
    herbal medicine and send it to me in , i took it and i saw changes on me
    thanks to dr jatto you are the best.👍👍👍 *
    * contact him now +12564174927 or website address http://drjattosolutionhome.webs.com
    drjattosolutionhome@gmail.com

    *NOTE THAT THESE GREAT MAN CAN CURE ANY TYPES OF SICKNESS AND DISEASE

    FUNGAL INFECTION
    *VIRAL INFECTION
    *PEYRON'ES DISEASE*
    *HERPES*
    *ALS*
    *CANCER*
    *HIV*
    *LOW SPERM COUNT*
    *PENIS ENLARGEMENT*
    *HEPATITIS A B C
    *STROKE*
    *MOLLUSCUM*
    *PLANTAR WART*
    *DIABETES*
    *INFERTILITY...............and more*...........

    ReplyDelete